| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | microfilament motor activity | 1.15e-07 | 38 | 208 | 7 | GO:0000146 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.07e-06 | 118 | 208 | 9 | GO:0003774 | |
| GeneOntologyMolecularFunction | calmodulin binding | MYH6 MYH9 MYO5A MYO7A MYO10 RYR2 SCN2A SCN3A IQGAP3 MYH14 TJP1 MYO15A | 5.58e-06 | 230 | 208 | 12 | GO:0005516 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DHX36 MYH6 MYH9 ABCA4 TDRD9 MYO5A MYO7A MYO10 ABCB4 KIF28P DNAH9 ABCG5 ABCC1 DDX49 DHX40 FANCM MYH14 MYO15A POLQ ATP5F1A | 7.05e-06 | 614 | 208 | 20 | GO:0140657 |
| GeneOntologyMolecularFunction | actin filament binding | MYH6 MYH9 MYO5A MYO7A MYO10 ANXA8L1 IQGAP3 ANXA8 MYH14 MYO15A | 1.40e-04 | 227 | 208 | 10 | GO:0051015 |
| GeneOntologyMolecularFunction | axon guidance receptor activity | 2.95e-04 | 13 | 208 | 3 | GO:0008046 | |
| GeneOntologyBiologicalProcess | actin filament-based movement | MYH6 MYH9 MYO5A MYO7A RYR2 KCNJ2 SCN2A SYNE2 SCN3A SCN10A CASQ2 MYH14 | 5.12e-08 | 153 | 208 | 12 | GO:0030048 |
| GeneOntologyBiologicalProcess | actin filament-based process | MYH6 MYH9 MYO5A MYO7A RYR2 NRP1 KCNJ2 SCN2A SYNE2 SCN3A SCN10A PCDH15 PREX1 IQGAP3 CLASP1 CASP5 CASQ2 SEMA5A PPARGC1B MYH14 TJP1 ARHGAP12 ARHGEF2 MYO15A | 1.76e-05 | 912 | 208 | 24 | GO:0030029 |
| GeneOntologyBiologicalProcess | protein localization to cell junction | 1.98e-05 | 148 | 208 | 9 | GO:1902414 | |
| GeneOntologyBiologicalProcess | regulation of dendrite development | 2.21e-05 | 150 | 208 | 9 | GO:0050773 | |
| GeneOntologyCellularComponent | myosin complex | 1.92e-06 | 59 | 208 | 7 | GO:0016459 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | MYH9 MYO7A CDH23 PCDH15 CALB1 RAPGEF4 LOXHD1 LCTL MYH14 SLC28A1 MYO15A | 1.53e-05 | 223 | 208 | 11 | GO:0098862 |
| GeneOntologyCellularComponent | actin-based cell projection | MYO5A MYO7A MYO10 ITGA6 CDH23 SYNE2 PCDH15 CALB1 CBR1 CRB1 LOXHD1 MYO15A | 2.38e-05 | 278 | 208 | 12 | GO:0098858 |
| GeneOntologyCellularComponent | neuronal cell body | EPHB2 DHX36 ERBB4 MYO5A MYO10 NRP1 NEFM PTPRS KCNJ2 SCN3A OGT CALB1 HTR7 PTBP2 RAPGEF4 CASP5 GRIP1 SLC12A2 VPS35 ROBO1 ARHGEF2 SEZ6 | 3.23e-05 | 835 | 208 | 22 | GO:0043025 |
| GeneOntologyCellularComponent | stereocilium | 6.42e-05 | 69 | 208 | 6 | GO:0032420 | |
| GeneOntologyCellularComponent | presynaptic membrane | EPHB2 ERBB4 CACNA2D2 PCDH17 NRXN2 PTPRS SCN2A SCN10A HTR7 ADGRL1 GRIP1 | 1.10e-04 | 277 | 208 | 11 | GO:0042734 |
| GeneOntologyCellularComponent | stereocilium bundle | 1.37e-04 | 79 | 208 | 6 | GO:0032421 | |
| GeneOntologyCellularComponent | cell body | EPHB2 DHX36 ERBB4 MYO5A MYO10 NRP1 NEFM PTPRS KCNJ2 SCN3A OGT CALB1 HTR7 PTBP2 RAPGEF4 CASP5 GRIP1 SLC12A2 VPS35 ROBO1 ARHGEF2 SEZ6 | 1.53e-04 | 929 | 208 | 22 | GO:0044297 |
| GeneOntologyCellularComponent | axon | EPHB2 DHX36 MYO5A GIT2 NRP1 NEFM DST PTPRS SCN2A SCN3A SCN10A PREX1 CALB1 HTR7 PTBP2 RAPGEF4 ADGRL1 EXOC8 GRIP1 MYH14 ROBO1 | 2.32e-04 | 891 | 208 | 21 | GO:0030424 |
| GeneOntologyCellularComponent | myosin II filament | 2.94e-04 | 3 | 208 | 2 | GO:0097513 | |
| GeneOntologyCellularComponent | distal axon | MYO5A GIT2 NRP1 PTPRS PREX1 CALB1 HTR7 PTBP2 RAPGEF4 ADGRL1 EXOC8 GRIP1 MYH14 | 4.39e-04 | 435 | 208 | 13 | GO:0150034 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.96e-04 | 17 | 208 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | growth cone | 8.07e-04 | 245 | 208 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 8.59e-04 | 111 | 208 | 6 | GO:0001750 | |
| GeneOntologyCellularComponent | cell-cell junction | MYH9 ITGA6 EVPL PCDH12 ITGAL ABCB4 DST KCNJ2 SCN2A TJP2 IQGAP3 CRB1 TJP1 SKAP1 ARHGEF2 | 8.85e-04 | 591 | 208 | 15 | GO:0005911 |
| GeneOntologyCellularComponent | site of polarized growth | 1.01e-03 | 253 | 208 | 9 | GO:0030427 | |
| GeneOntologyCellularComponent | cell cortex | MYH9 MYO7A MYO10 DST IQGAP3 CALB1 CLASP1 EXOC8 GRIP1 CLIP3 GPSM1 | 1.28e-03 | 371 | 208 | 11 | GO:0005938 |
| GeneOntologyCellularComponent | glutamatergic synapse | EPHB2 ERBB4 MYO5A PCDH17 NRP1 NRXN2 PTPRS KCNJ2 SCN2A SCN10A OGT CALB1 RAPGEF4 ADGRL1 ARHGAP39 GRIP1 VPS35 ARHGEF2 | 1.40e-03 | 817 | 208 | 18 | GO:0098978 |
| GeneOntologyCellularComponent | monoatomic ion channel complex | CACNA2D2 CHRNB1 RYR2 KCNJ2 SCN2A SCN3A SCN10A GPR89A GPR89B CASQ2 ATP5F1A | 1.48e-03 | 378 | 208 | 11 | GO:0034702 |
| GeneOntologyCellularComponent | anchoring junction | MYH9 ITGA6 EVPL GIT2 PCDH12 ITGAL ABCB4 NRP1 DST KCNJ2 SCN2A SYNE2 TJP2 CAPN5 IQGAP3 CLASP1 CRB1 TJP1 SKAP1 ARHGEF2 | 1.82e-03 | 976 | 208 | 20 | GO:0070161 |
| GeneOntologyCellularComponent | myosin filament | 1.90e-03 | 25 | 208 | 3 | GO:0032982 | |
| GeneOntologyCellularComponent | membrane attack complex | 2.00e-03 | 7 | 208 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | synaptic membrane | EPHB2 ERBB4 CACNA2D2 CHRNB1 PCDH17 NRP1 NRXN2 PTPRS KCNJ2 SCN2A SCN10A HTR7 ADGRL1 GRIP1 | 2.19e-03 | 583 | 208 | 14 | GO:0097060 |
| GeneOntologyCellularComponent | transmembrane transporter complex | CACNA2D2 NDUFV1 CHRNB1 RYR2 KCNJ2 SCN2A SCN3A SCN10A GPR89A ABCG5 GPR89B CASQ2 ATP5F1A | 2.32e-03 | 523 | 208 | 13 | GO:1902495 |
| GeneOntologyCellularComponent | cell-cell contact zone | 2.49e-03 | 94 | 208 | 5 | GO:0044291 | |
| GeneOntologyCellularComponent | cation channel complex | 2.51e-03 | 235 | 208 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | microtubule plus-end | 2.65e-03 | 28 | 208 | 3 | GO:0035371 | |
| GeneOntologyCellularComponent | myosin II complex | 2.65e-03 | 28 | 208 | 3 | GO:0016460 | |
| GeneOntologyCellularComponent | somatodendritic compartment | EPHB2 DHX36 ERBB4 MYO5A MYO10 NRP1 NEFM PTPRS KCNJ2 SCN3A PREX1 OGT CALB1 HTR7 PTBP2 RAPGEF4 CASP5 GRIP1 SLC12A2 VPS35 ROBO1 ARHGEF2 SEZ6 | 2.67e-03 | 1228 | 208 | 23 | GO:0036477 |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 2.71e-03 | 139 | 208 | 6 | GO:0097733 | |
| GeneOntologyCellularComponent | sodium channel complex | 2.93e-03 | 29 | 208 | 3 | GO:0034706 | |
| MousePheno | abnormal cochlear hair cell inter-stereocilial links morphology | 2.98e-06 | 9 | 177 | 4 | MP:0004577 | |
| MousePheno | head bobbing | 3.35e-06 | 51 | 177 | 7 | MP:0001410 | |
| MousePheno | abnormal stationary movement | EPHB2 CACNA2D2 MYO7A CDH23 DST SERPINB12 SCN10A PCDH15 SLC12A2 MYO15A | 1.75e-05 | 147 | 177 | 10 | MP:0001388 |
| MousePheno | head tilt | 1.79e-05 | 44 | 177 | 6 | MP:0005191 | |
| MousePheno | abnormal head movements | 4.82e-05 | 103 | 177 | 8 | MP:0000436 | |
| MousePheno | vestibular saccular degeneration | 6.73e-05 | 7 | 177 | 3 | MP:0004329 | |
| MousePheno | impaired righting response | HECW1 MYO5A MYO7A CDH23 RXYLT1 FBXO10 DST SCN10A PCDH15 RNF25 | 9.82e-05 | 180 | 177 | 10 | MP:0001523 |
| Domain | IQ | MYH6 MYH9 MYO5A MYO7A MYO10 LRRIQ1 SCN3A SCN10A IQGAP3 MYH14 UBE3C MYO15A | 1.52e-11 | 71 | 204 | 12 | PF00612 |
| Domain | IQ_motif_EF-hand-BS | MYH6 MYH9 MYO5A MYO7A MYO10 LRRIQ1 SCN2A SCN3A SCN10A IQGAP3 MYH14 UBE3C MYO15A | 1.69e-11 | 90 | 204 | 13 | IPR000048 |
| Domain | IQ | MYH6 MYH9 MYO5A MYO7A MYO10 LRRIQ1 SCN2A SCN3A SCN10A IQGAP3 MYH14 UBE3C MYO15A | 2.59e-11 | 93 | 204 | 13 | PS50096 |
| Domain | IQ | MYH6 MYH9 MYO5A MYO7A MYO10 LRRIQ1 SCN2A SCN3A IQGAP3 MYH14 UBE3C MYO15A | 7.62e-11 | 81 | 204 | 12 | SM00015 |
| Domain | Myosin_head_motor_dom | 1.58e-07 | 38 | 204 | 7 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 1.58e-07 | 38 | 204 | 7 | PS51456 | |
| Domain | Myosin_head | 1.58e-07 | 38 | 204 | 7 | PF00063 | |
| Domain | MYSc | 1.58e-07 | 38 | 204 | 7 | SM00242 | |
| Domain | MYTH4 | 1.67e-06 | 9 | 204 | 4 | PS51016 | |
| Domain | MyTH4 | 1.67e-06 | 9 | 204 | 4 | SM00139 | |
| Domain | MyTH4_dom | 1.67e-06 | 9 | 204 | 4 | IPR000857 | |
| Domain | MyTH4 | 1.67e-06 | 9 | 204 | 4 | PF00784 | |
| Domain | P-loop_NTPase | DHX36 MYH6 MYH9 ABCA4 TDRD9 MYO5A MYO7A MYO10 ABCB4 GUF1 LRRIQ1 UCKL1 TJP2 DNAH9 ABCG5 ABCC1 DDX49 DHX40 GAL3ST4 FANCM MYH14 TJP1 MYO15A POLQ ATP5F1A | 6.34e-06 | 848 | 204 | 25 | IPR027417 |
| Domain | AnnexinVIII | 1.19e-04 | 2 | 204 | 2 | IPR009115 | |
| Domain | HECW_N | 1.19e-04 | 2 | 204 | 2 | IPR032348 | |
| Domain | HECW_N | 1.19e-04 | 2 | 204 | 2 | PF16562 | |
| Domain | Na_channel_asu | 1.46e-04 | 10 | 204 | 3 | IPR001696 | |
| Domain | Na_trans_assoc | 1.46e-04 | 10 | 204 | 3 | IPR010526 | |
| Domain | Na_trans_assoc | 1.46e-04 | 10 | 204 | 3 | PF06512 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.46e-04 | 73 | 204 | 6 | IPR011545 | |
| Domain | DEAD | 1.46e-04 | 73 | 204 | 6 | PF00270 | |
| Domain | HECT | 1.99e-04 | 27 | 204 | 4 | PF00632 | |
| Domain | HECTc | 1.99e-04 | 27 | 204 | 4 | SM00119 | |
| Domain | HECT_dom | 1.99e-04 | 27 | 204 | 4 | IPR000569 | |
| Domain | HECT | 1.99e-04 | 27 | 204 | 4 | PS50237 | |
| Domain | ZO | 3.54e-04 | 3 | 204 | 2 | IPR005417 | |
| Domain | Vps51 | 3.54e-04 | 3 | 204 | 2 | IPR014812 | |
| Domain | Myosin_N | 5.30e-04 | 15 | 204 | 3 | PF02736 | |
| Domain | Myosin_N | 5.30e-04 | 15 | 204 | 3 | IPR004009 | |
| Domain | 3HC_DH_C | 7.02e-04 | 4 | 204 | 2 | IPR006108 | |
| Domain | 3HCDH | 7.02e-04 | 4 | 204 | 2 | PS00067 | |
| Domain | 3HCDH | 7.02e-04 | 4 | 204 | 2 | PF00725 | |
| Domain | 3-OHacyl-CoA_DH_NAD-bd | 7.02e-04 | 4 | 204 | 2 | IPR006176 | |
| Domain | 3-OHacyl-CoA_DH_CS | 7.02e-04 | 4 | 204 | 2 | IPR006180 | |
| Domain | 3HCDH_N | 7.02e-04 | 4 | 204 | 2 | PF02737 | |
| Domain | Myosin_tail_1 | 9.28e-04 | 18 | 204 | 3 | PF01576 | |
| Domain | Myosin_tail | 9.28e-04 | 18 | 204 | 3 | IPR002928 | |
| Domain | HA2 | 9.28e-04 | 18 | 204 | 3 | SM00847 | |
| Domain | HA2 | 9.28e-04 | 18 | 204 | 3 | PF04408 | |
| Domain | Helicase-assoc_dom | 9.28e-04 | 18 | 204 | 3 | IPR007502 | |
| Domain | Myosin-like_IQ_dom | 1.09e-03 | 19 | 204 | 3 | IPR027401 | |
| Domain | - | 1.09e-03 | 19 | 204 | 3 | 4.10.270.10 | |
| Domain | Helicase_C | 1.14e-03 | 107 | 204 | 6 | PF00271 | |
| Domain | HELICc | 1.14e-03 | 107 | 204 | 6 | SM00490 | |
| Domain | Helicase_C | 1.20e-03 | 108 | 204 | 6 | IPR001650 | |
| Domain | HELICASE_CTER | 1.26e-03 | 109 | 204 | 6 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.26e-03 | 109 | 204 | 6 | PS51192 | |
| Domain | DEXDc | 1.26e-03 | 109 | 204 | 6 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.32e-03 | 110 | 204 | 6 | IPR014001 | |
| Domain | - | DHX36 ABCA4 TDRD9 MYO7A ABCB4 GUF1 UCKL1 TJP2 DNAH9 ABCG5 ABCC1 DDX49 DHX40 FANCM TJP1 MYO15A POLQ ATP5F1A | 1.42e-03 | 746 | 204 | 18 | 3.40.50.300 |
| Domain | WW | 1.71e-03 | 47 | 204 | 4 | PF00397 | |
| Domain | - | 1.73e-03 | 6 | 204 | 2 | 3.90.1290.10 | |
| Domain | Na_trans_cytopl | 1.73e-03 | 6 | 204 | 2 | PF11933 | |
| Domain | Na_trans_cytopl | 1.73e-03 | 6 | 204 | 2 | IPR024583 | |
| Domain | ABC_tran | 1.85e-03 | 48 | 204 | 4 | PF00005 | |
| Domain | WW | 1.85e-03 | 48 | 204 | 4 | SM00456 | |
| Domain | ABC_TRANSPORTER_2 | 1.85e-03 | 48 | 204 | 4 | PS50893 | |
| Pubmed | MTA2 DHX36 MYH6 MYH9 MYO5A MYO7A DDB1 NDUFV1 NEFM DST NRXN2 PTPRS HECW2 SCN2A OSBPL6 TJP2 SLC25A11 ALDH1B1 VPS51 TARS1 OGT CLASP1 RAPGEF4 ADGRL1 ARHGAP39 CBR1 YARS1 MYH14 TJP1 CSNK2A2 VPS35 HADHA ARHGEF2 ATP5F1A | 9.93e-12 | 1431 | 211 | 34 | 37142655 | |
| Pubmed | MTA2 DHX36 MYH9 MYO5A ANKHD1 DDB1 GFPT1 NEFM DST SYNE2 TJP2 ANKRD52 PUF60 NSD2 RBM28 IGF2BP3 MYH14 TJP1 CSNK2A2 LTA4H HADHA NNT | 1.05e-10 | 653 | 211 | 22 | 22586326 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | MTA2 DHX36 MYH9 DIS3L2 MYO5A PSMD13 ANKHD1 DDB1 GFPT1 GUF1 DST MAGED2 SERPINB12 TUBGCP3 SLC25A11 ALDH1B1 MRPL49 ANKRD52 TARS1 DDX49 TBPL1 DHX40 ISOC1 RBM28 CBR1 MYH14 VPS35 HADHA ARHGEF2 ATP5F1A | 9.61e-10 | 1353 | 211 | 30 | 29467282 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDXDC1 DHX36 MYH9 NEK6 PSMD13 GIT2 PTPRS WRAP73 TJP2 PYGM PREX1 TARS1 OGT CLASP1 PUF60 TBPL1 CBR1 YARS1 CRB1 IGF2BP3 LOXHD1 CSNK2A2 VPS35 LTA4H IRS2 HADHA ARHGEF2 POLQ | 5.29e-09 | 1284 | 211 | 28 | 17353931 |
| Pubmed | 1.10e-08 | 70 | 211 | 8 | 20301607 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | MTA2 DHX36 MYH9 CACNA2D2 PSMD13 ANKHD1 DDB1 GFPT1 NDUFV1 MAGED2 SERPINB12 SLC25A11 ALDH1B1 TALDO1 IQGAP3 TARS1 PITRM1 PUF60 NSD2 CBR1 YARS1 MYH14 CSNK2A2 VPS35 PLPBP HADHA UBE3C NNT ATP5F1A | 1.26e-08 | 1425 | 211 | 29 | 30948266 |
| Pubmed | PDXDC1 MTA2 MYH9 PSMD13 NDUFV1 MAGED2 HINT2 SLC25A11 ALDH1B1 TARS1 ABCC1 PITRM1 CBR1 CBR3 YARS1 EXOC8 TKFC VPS35 LTA4H HADHA NNT ATP5F1A | 2.37e-08 | 878 | 211 | 22 | 37223481 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PDXDC1 MTA2 EVPL PSMD13 ANKHD1 DDB1 GFPT1 RCOR1 PTPRS TJP2 ANKRD52 OGT PITRM1 CLASP1 DHX40 RBM28 EXOC8 TJP1 CSNK2A2 VPS35 IRS2 UBE3C GPSM1 | 3.29e-08 | 974 | 211 | 23 | 28675297 |
| Pubmed | Role of myosin VIIa and Rab27a in the motility and localization of RPE melanosomes. | 4.54e-08 | 7 | 211 | 4 | 15572405 | |
| Pubmed | 4.54e-08 | 7 | 211 | 4 | 21436032 | ||
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MTA2 DHX36 MYH9 DDB1 NDUFV1 NEFM DST NRXN2 TUBGCP3 PCDH15 SLC25A11 MRPL49 OGT DDX49 CLASP1 PTBP2 PUF60 NSD2 ARHGAP39 SIK3 IGF2BP3 TJP1 HADHA ARHGEF2 | 5.24e-08 | 1082 | 211 | 24 | 38697112 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MTA2 DHX36 MYH9 MYO5A ITGA6 EVPL PSMD13 DDB1 GFPT1 DST MAGED2 SERPINB12 TJP2 SLC25A11 IQGAP3 TARS1 PUF60 ISOC1 RBM28 YARS1 TJP1 CSNK2A2 GAN HADHA ARHGEF2 ATP5F1A | 5.58e-08 | 1257 | 211 | 26 | 36526897 |
| Pubmed | PDXDC1 MTA2 PSMD13 DDB1 NDUFV1 RCOR1 MAGED2 TUBGCP3 SLC25A11 VPS51 COPS6 PTBP2 EXOC8 VPS35 HADHA NNT ATP5F1A | 6.87e-08 | 560 | 211 | 17 | 35241646 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | PDXDC1 MYH9 PSMD13 DDB1 GFPT1 GUF1 DST SLC25A11 TALDO1 IQGAP3 TARS1 PUF60 ISOC1 SLC12A2 MYH14 LTA4H HADHA MYO15A NNT ATP5F1A | 1.27e-07 | 807 | 211 | 20 | 30575818 |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MTA2 MYH9 MYO5A PSMD13 ANKHD1 DDB1 NEFM DST LRRIQ1 MAGED2 COPS6 TALDO1 IQGAP3 TARS1 OGT PUF60 CBR1 YARS1 IGF2BP3 CSNK2A2 VPS35 LTA4H HADHA ATP5F1A | 1.58e-07 | 1149 | 211 | 24 | 35446349 |
| Pubmed | 1.62e-07 | 9 | 211 | 4 | 19339464 | ||
| Pubmed | Genetic background of catecholaminergic polymorphic ventricular tachycardia in Japan. | 2.20e-07 | 3 | 211 | 3 | 23595086 | |
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 16679490 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MTA2 MGAT4B MYO7A MYO10 ANKHD1 PLEKHM1 DST PTPRS UCKL1 SLC35A2 PREX1 IQGAP3 PUF60 NSD2 SLC35B3 ADGRL1 TKFC HPS6 HMGXB3 IRS2 UBE3C ARHGEF2 GGA1 | 3.10e-07 | 1105 | 211 | 23 | 35748872 |
| Pubmed | MTA2 MYH9 GIT2 GFPT1 RCOR1 MAGED2 TUBGCP3 TARS1 IGF2BP3 TKFC HADHA ARHGEF2 | 3.26e-07 | 298 | 211 | 12 | 30737378 | |
| Pubmed | Poly(ADP-ribosyl)ation of BRD7 by PARP1 confers resistance to DNA-damaging chemotherapeutic agents. | DHX36 MYH9 MAGED2 SLC25A11 ALDH1B1 IQGAP3 DDX49 PTBP2 PUF60 DHX40 IGF2BP3 TJP1 HADHA UBE3C ATP5F1A | 3.37e-07 | 486 | 211 | 15 | 30940648 |
| Pubmed | The protein network surrounding the human telomere repeat binding factors TRF1, TRF2, and POT1. | 3.92e-07 | 197 | 211 | 10 | 20811636 | |
| Pubmed | ABCA4 MYO7A GFPT1 RYR2 SYNE2 C5 ANKRD52 PREX1 GPR89B HECTD3 TBPL1 DHX40 SIK3 CRYL1 CSNK2A2 IRS2 ARHGEF2 | 4.30e-07 | 638 | 211 | 17 | 31182584 | |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | DHX36 MYH9 PSMD13 ANKHD1 DDB1 GFPT1 SYNE2 SLC25A11 MRPL49 TARS1 OGT CLASP1 AAMDC PUF60 ISOC1 CBR1 YARS1 IGF2BP3 TJP1 CSNK2A2 VPS35 PLPBP IRS2 HADHA ARHGEF2 ATP5F1A | 5.44e-07 | 1415 | 211 | 26 | 28515276 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | PDXDC1 MYO5A PSMD13 NRP1 MAGED2 PTPRS HECW2 SLC12A2 CSNK2A2 HADHA UBE3C ARHGEF2 | 5.49e-07 | 313 | 211 | 12 | 38270169 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | MYH9 MYO7A EVPL GFPT1 PCDH17 FBXO10 DST HECW2 SCN3A C6 PCDHGB3 BAZ2B RBM28 IGF2BP3 LOXHD1 LTA4H HADHA SERPINA9 | 6.72e-07 | 736 | 211 | 18 | 29676528 |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 16481439 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 8690736 | ||
| Pubmed | Control of stereocilia length during development of hair bundles. | 8.77e-07 | 4 | 211 | 3 | 37011103 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 30275467 | ||
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | MYH9 MYO10 PSMD13 YAE1 TUBGCP3 WRAP73 TJP2 SLC25A11 COPS6 ANKRD52 OGT DHX40 CBR3 EXOC8 TJP1 CSNK2A2 VPS35 UGGT2 HADHA VSIG8 ARHGEF2 | 9.81e-07 | 1005 | 211 | 21 | 19615732 |
| Pubmed | MTA2 MYH9 ANKHD1 DDB1 GFPT1 NRP1 MAGED2 SERPINB12 TUBGCP3 TJP2 SLC25A11 C5 TALDO1 CLASP1 PUF60 ISOC1 RBM28 IGF2BP3 TKFC MYH14 TJP1 CSNK2A2 HADHA ARHGEF2 ATP5F1A | 1.05e-06 | 1371 | 211 | 25 | 36244648 | |
| Pubmed | 1.26e-06 | 14 | 211 | 4 | 8022818 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | MTA2 MYO5A DDB1 NRP1 DST SERPINB12 SYNE2 TJP2 HINT2 TARS1 PUF60 RBM28 CBR1 IGF2BP3 SLC12A2 MYH14 TJP1 HADHA ARHGEF2 NNT ATP5F1A | 1.32e-06 | 1024 | 211 | 21 | 24711643 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | PDXDC1 DHX36 PSMD13 DDB1 NDUFV1 GUF1 DST MAGED2 SYNE2 WRAP73 GPR89A HINT2 MIGA1 ALDH1B1 MRPL49 PITRM1 RBM28 YARS1 IGF2BP3 SLC12A2 ARHGAP12 HADHA UBE3C ARHGEF2 NNT ATP5F1A | 1.53e-06 | 1496 | 211 | 26 | 32877691 |
| Pubmed | The protocadherin gene Celsr3 is required for interneuron migration in the mouse forebrain. | 1.71e-06 | 15 | 211 | 4 | 19332558 | |
| Pubmed | Targeting RICTOR Sensitizes SMAD4-Negative Colon Cancer to Irinotecan. | 1.96e-06 | 183 | 211 | 9 | 31932471 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MYH9 MYO5A ANKHD1 DDB1 MKS1 NEFM IQGAP3 KLHL4 OGT CALB1 SIK3 YARS1 HADHA MYO15A ATP5F1A | 2.14e-06 | 564 | 211 | 15 | 21565611 |
| Pubmed | Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population. | 2.18e-06 | 5 | 211 | 3 | 15660226 | |
| Pubmed | Morphogenesis and Compartmentalization of the Intestinal Crypt. | 2.18e-06 | 5 | 211 | 3 | 29689194 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 22381527 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 26092122 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 1679748 | ||
| Pubmed | Interactions in the network of Usher syndrome type 1 proteins. | 2.18e-06 | 5 | 211 | 3 | 15590703 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 20332152 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 16219682 | ||
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 17615572 | ||
| Pubmed | MYH6 MYH9 MYO5A TKTL1 RYR2 ABCB4 NEFM DST MAGED2 SYNE2 ALDH1B1 KIAA2012 PREX1 PCDHGB3 PTBP2 NSD2 MYH14 TJP1 ARHGAP12 VPS35 UGGT2 HADHA ARHGEF2 POLQ ATP5F1A | 2.58e-06 | 1442 | 211 | 25 | 35575683 | |
| Pubmed | DHX36 MGAT4B ANKHD1 NRP1 DST TUBGCP3 SLC25A11 IQGAP3 OGT HECTD3 DHX40 SIK3 EXOC8 LPL UGGT2 ARHGEF2 | 2.63e-06 | 650 | 211 | 16 | 38777146 | |
| Pubmed | 2.79e-06 | 191 | 211 | 9 | 33762435 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PDXDC1 MTA2 MYH9 PSMD13 DDB1 GFPT1 MAGED2 TJP2 ALDH1B1 COPS6 TALDO1 TARS1 OGT HECTD3 PUF60 ISOC1 YARS1 IGF2BP3 TKFC MYH14 CSNK2A2 VPS35 PLPBP INTS9 UBE3C | 3.02e-06 | 1455 | 211 | 25 | 22863883 |
| Pubmed | MTA2 DDB1 GFPT1 NEFM MAGED2 TJP2 SLC25A11 TARS1 CBR1 TJP1 GAN LTA4H HADHA | 3.12e-06 | 437 | 211 | 13 | 20562859 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHB2 MTA2 MYH9 ITGA6 PSMD13 DDB1 GFPT1 MAGED2 SERPINB12 SYNE2 TJP2 SLC25A11 COPS6 TALDO1 CLASP1 AAMDC PUF60 CBR1 TJP1 LTA4H HADHA VSIG8 NNT ATP5F1A | 3.35e-06 | 1367 | 211 | 24 | 32687490 |
| Pubmed | TMHS is an integral component of the mechanotransduction machinery of cochlear hair cells. | 4.34e-06 | 6 | 211 | 3 | 23217710 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 15034141 | ||
| Pubmed | A 'toothache tree' alkylamide inhibits Aδ mechanonociceptors to alleviate mechanical pain. | 4.34e-06 | 6 | 211 | 3 | 23652591 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 26620972 | ||
| Pubmed | PDXDC1 MYH9 DDB1 GFPT1 TARS1 PITRM1 PUF60 YARS1 IGF2BP3 VPS35 LTA4H NNT ATP5F1A | 4.39e-06 | 451 | 211 | 13 | 36168627 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHB2 MTA2 DHX36 MGAT4B MYH9 ITGA6 RXYLT1 DDB1 NRP1 NXPE3 PTPRS SLC35A2 TMCO3 GPR89B ABCC1 ISOC1 GLB1L2 SLC12A2 LPL VPS35 ROBO1 UGGT2 | 4.53e-06 | 1201 | 211 | 22 | 35696571 |
| Pubmed | MYH6 MYH9 GFPT1 NEFM DST MAGED2 SERPINB12 PYGM SLC25A11 MRPL49 TARS1 PUF60 YARS1 MYH14 PLPBP HADHA VSIG8 ATP5F1A | 4.57e-06 | 844 | 211 | 18 | 25963833 | |
| Pubmed | MYH6 NDUFV1 RYR2 DST HINT2 PYGM PITRM1 CASQ2 HADHA NNT ATP5F1A | 6.44e-06 | 331 | 211 | 11 | 29199018 | |
| Pubmed | Novel gene function revealed by mouse mutagenesis screens for models of age-related disease. | 7.02e-06 | 44 | 211 | 5 | 27534441 | |
| Pubmed | Repression of rRNA transcription by PARIS contributes to Parkinson's disease. | DDB1 MAGED2 SLC25A11 ALDH1B1 PUF60 RBM28 IGF2BP3 MYH14 HADHA ATP5F1A | 7.10e-06 | 272 | 211 | 10 | 25315684 |
| Pubmed | MTA2 MAGED2 SLC25A11 ALDH1B1 IQGAP3 DDX49 CSNK2A2 HADHA ARHGEF2 | 7.29e-06 | 215 | 211 | 9 | 30462309 | |
| Pubmed | MYH9 HECW1 MYO5A GIT2 DDB1 NEFM RCOR1 DST MAGED2 PTPRS SYNE2 OGT CLASP1 RAPGEF4 ARHGAP39 SIK3 TJP1 CSNK2A2 ARHGEF2 | 7.47e-06 | 963 | 211 | 19 | 28671696 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 11212352 | ||
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 13853422 | ||
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 16962269 | ||
| Pubmed | Cochlear histopathology of the mutant bustling mouse, BUS/Idr. | 7.57e-06 | 7 | 211 | 3 | 8790740 | |
| Pubmed | 7.57e-06 | 7 | 211 | 3 | 20301442 | ||
| Pubmed | Histone deacetylase 1 phosphorylation promotes enzymatic activity and complex formation. | 7.57e-06 | 7 | 211 | 3 | 11602581 | |
| Pubmed | PDXDC1 ANKHD1 DDB1 GFPT1 NDUFV1 TJP2 SLC25A11 ALDH1B1 ABCC1 PUF60 CBR1 YARS1 IGF2BP3 TKFC MYH14 ATP5F1A | 8.13e-06 | 711 | 211 | 16 | 33022573 | |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 8.63e-06 | 119 | 211 | 7 | 35776542 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | PSMD13 ANKHD1 DDB1 MAGED2 SLC25A11 VPS51 COPS6 ANKRD52 TARS1 OGT HECTD3 CSNK2A2 VPS35 ATP5F1A | 1.18e-05 | 571 | 211 | 14 | 37167062 |
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 15702992 | ||
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 1.21e-05 | 8 | 211 | 3 | 19683999 | |
| Pubmed | Stereocilin connects outer hair cell stereocilia to one another and to the tectorial membrane. | 1.21e-05 | 8 | 211 | 3 | 21165971 | |
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 18484607 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 20301466 | ||
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 16545802 | ||
| Pubmed | PDXDC1 MTA2 MYH9 PSMD13 DDB1 MAGED2 TUBGCP3 SLC25A11 ALDH1B1 OGT HECTD3 YARS1 EXOC8 ARHGAP12 ATP5F1A | 1.33e-05 | 657 | 211 | 15 | 36180527 | |
| Pubmed | NDUFV1 NEFM TUBGCP3 OSBPL6 TJP2 SLC25A11 CLASP1 PUF60 ADGRL1 ARHGAP39 GRIP1 CLIP3 | 1.42e-05 | 430 | 211 | 12 | 32581705 | |
| Pubmed | MET Inhibitors Promote Liver Tumor Evasion of the Immune Response by Stabilizing PDL1. | 1.66e-05 | 182 | 211 | 8 | 30711629 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 31605013 | ||
| Pubmed | Elongation factor 1 alpha1 and genes associated with Usher syndromes are downstream targets of GBX2. | 1.80e-05 | 9 | 211 | 3 | 23144817 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 16382098 | ||
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 18339676 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | MTA2 MYO7A CDH23 PSMD13 GIT2 MKS1 NEFM RCOR1 MAGED2 OSBPL6 VPS51 COPS6 IQGAP3 GPR89B OGT PITRM1 CLASP1 EXOC8 GAN UGGT2 VSIG8 GGA1 | 1.98e-05 | 1321 | 211 | 22 | 27173435 |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 2.02e-05 | 91 | 211 | 6 | 34445801 | |
| Pubmed | MYH9 GIT2 ANKHD1 GFPT1 SLC25A11 PUF60 RBM28 IGF2BP3 MYH14 TJP1 CSNK2A2 VPS35 ARHGEF2 ATP5F1A | 2.08e-05 | 601 | 211 | 14 | 33658012 | |
| Pubmed | Nolz1 expression is required in dopaminergic axon guidance and striatal innervation. | 2.13e-05 | 55 | 211 | 5 | 32561725 | |
| Pubmed | Harnessing host enhancers of SARS-CoV-2 entry as novel targets for antiviral therapy. | 2.13e-05 | 55 | 211 | 5 | 38945485 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | PSMD13 GFPT1 NEFM TALDO1 TARS1 PUF60 CBR1 YARS1 IGF2BP3 MYH14 CSNK2A2 VPS35 HADHA NNT | 2.31e-05 | 607 | 211 | 14 | 39147351 |
| Pubmed | MTA2 DHX36 PSMD13 ANKHD1 DDB1 RCOR1 MAGED2 SLC25A11 ALDH1B1 COPS6 MRPL49 TARS1 PUF60 DHX40 ISOC1 IGF2BP3 CSNK2A2 VPS35 INTS9 HADHA ARHGEF2 ATP5F1A | 2.32e-05 | 1335 | 211 | 22 | 29229926 | |
| Pubmed | PDXDC1 MYH9 RYR2 MKS1 DST MAGED2 TJP2 TARS1 CRB1 IGF2BP3 SLC12A2 TJP1 PWWP3A ROBO1 GGA1 ATP5F1A | 2.41e-05 | 777 | 211 | 16 | 35844135 | |
| Pubmed | Massively parallel DNA sequencing facilitates diagnosis of patients with Usher syndrome type 1. | 2.56e-05 | 10 | 211 | 3 | 24618850 | |
| Pubmed | 2.56e-05 | 10 | 211 | 3 | 17329413 | ||
| Pubmed | 2.56e-05 | 10 | 211 | 3 | 24239741 | ||
| Pubmed | PSMD13 ANKHD1 DDB1 GFPT1 RCOR1 SLC25A11 TALDO1 YARS1 IGF2BP3 VPS35 LTA4H HADHA NNT | 2.61e-05 | 534 | 211 | 13 | 35032548 | |
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | MTA2 MYH6 MYO5A NDUFV1 NEFM DST PYGM SLC25A11 CALB1 CBR1 CSNK2A2 VPS35 ARHGEF2 ATP5F1A | 2.97e-05 | 621 | 211 | 14 | 22794259 |
| Interaction | KCTD13 interactions | MTA2 DHX36 MYH6 MYH9 MYO5A MYO7A DDB1 NDUFV1 NEFM DST NRXN2 PTPRS HECW2 SCN2A OSBPL6 TJP2 SLC25A11 ALDH1B1 VPS51 TARS1 ARMC7 OGT CLASP1 RAPGEF4 ADGRL1 ARHGAP39 CBR1 YARS1 MYH14 TJP1 CSNK2A2 VPS35 HADHA ARHGEF2 ATP5F1A | 7.57e-07 | 1394 | 207 | 35 | int:KCTD13 |
| Interaction | PRDM16 interactions | MTA2 NEK6 RCOR1 MAGED2 SLC25A11 IQGAP3 DDX49 MID2 CSNK2A2 HADHA ARHGEF2 | 5.78e-06 | 195 | 207 | 11 | int:PRDM16 |
| Interaction | NR3C1 interactions | MTA2 ABCA4 MYO7A GFPT1 RYR2 RCOR1 SYNE2 C5 ALDH1B1 COPS6 ANKRD52 PREX1 KLHL4 GPR89B ABCC1 HECTD3 TBPL1 DHX40 SIK3 GRIP1 CRYL1 CSNK2A2 IRS2 HADHA ARHGEF2 ATP5F1A | 8.15e-06 | 974 | 207 | 26 | int:NR3C1 |
| Interaction | SIRT7 interactions | MTA2 DHX36 MYH9 MYO5A ANKHD1 DDB1 GFPT1 NEFM DST SYNE2 TJP2 ANKRD52 PUF60 NSD2 RBM28 IGF2BP3 MYH14 TJP1 CSNK2A2 LTA4H HADHA NNT | 8.92e-06 | 744 | 207 | 22 | int:SIRT7 |
| Interaction | HDAC5 interactions | MTA2 MYH9 TNFSF10 DDB1 BHMT RCOR1 TUBGCP3 SLC25A11 TARS1 IKZF2 OGT SIK3 ARHGAP12 LTA4H HADHA ATP5F1A | 1.08e-05 | 432 | 207 | 16 | int:HDAC5 |
| Interaction | PKN3 interactions | MYO5A MYO10 GIT2 RCOR1 HECW2 VPS51 ANKRD52 IQGAP3 DHX40 SKAP1 | 1.85e-05 | 181 | 207 | 10 | int:PKN3 |
| Interaction | MYCBP2 interactions | EPHB2 MYO10 RCOR1 DST MAGED2 SYNE2 CLASP1 PUF60 NSD2 CASQ2 TJP1 SKAP1 VPS35 ARHGEF2 | 1.95e-05 | 355 | 207 | 14 | int:MYCBP2 |
| GeneFamily | Actins|Deafness associated genes | 5.04e-06 | 113 | 152 | 8 | 1152 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 4.72e-05 | 9 | 152 | 3 | 1203 | |
| GeneFamily | Myosin heavy chains | 2.46e-04 | 15 | 152 | 3 | 1098 | |
| GeneFamily | Kelch like|BTB domain containing | 4.19e-04 | 42 | 152 | 4 | 617 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.81e-03 | 206 | 152 | 7 | 682 | |
| GeneFamily | EF-hand domain containing|Plakins | 1.90e-03 | 8 | 152 | 2 | 939 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_AND_IL10_STIM_MACROPHAGE_UP | PDXDC1 MGAT4B C3orf33 PTPRS SYNE2 ALDH1B1 BAZ2B CBR1 EXOC8 HPS6 | 5.50e-06 | 200 | 211 | 10 | M6604 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#1_top-relative-expression-ranked_100 | 6.52e-07 | 33 | 204 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | ERBB4 CACNA2D2 MYO7A ITGA6 CDH23 FBLN2 DST HECW2 SYNE2 ALDH1B1 ADGRL1 SEMA5A LPL ROBO1 ELF4 | 2.05e-05 | 433 | 204 | 15 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_500 | ERBB4 CACNA2D2 MYO7A ITGA6 CDH23 FBLN2 DST HECW2 ALDH1B1 ADGRL1 SEMA5A ARHGAP39 LPL ROBO1 ELF4 | 2.54e-05 | 441 | 204 | 15 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000 | MYO5A GFPT1 PCDH17 RYR2 NXPE3 NEFM SCN3A MIGA1 NOVA1 OGT CLASP1 PTBP2 RAPGEF4 PELI1 GAL3ST4 SEMA5A GLB1L2 SLC12A2 ROBO1 RBM24 TNKS2 | 4.30e-05 | 818 | 204 | 21 | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | ERBB4 CACNA2D2 MYO7A ITGA6 CDH23 GFPT1 RCOR1 FBLN2 DST HECW2 SYNE2 ALDH1B1 RAPGEF4 ADGRL1 SEMA5A ARHGAP39 CBR3 CRYL1 LPL GAN ROBO1 ELF4 | 4.46e-05 | 884 | 204 | 22 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#5_top-relative-expression-ranked_200 | 5.29e-05 | 69 | 204 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_200_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | EPHB2 DHX36 NEK6 GANC MYO5A MYO10 GIT2 RXYLT1 ANKHD1 KLHL32 PLEKHM1 NEFM SYNE2 NOVA1 SCRN3 PTBP2 GRIP1 CLIP3 KLHL5 PLPBP POLQ | 5.39e-05 | 831 | 204 | 21 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#4_top-relative-expression-ranked_500 | 5.77e-05 | 138 | 204 | 8 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k4_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_top-relative-expression-ranked_1000 | ERBB4 CACNA2D2 MYO7A ITGA6 CDH23 RCOR1 FBLN2 DST HECW2 SYNE2 ALDH1B1 MID2 RAPGEF4 ADGRL1 SEMA5A ARHGAP39 CRYL1 LPL GAN ROBO1 ELF4 | 1.21e-04 | 880 | 204 | 21 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | PDXDC1 DHX36 MYH6 TDRD9 MYO7A MYO10 CDH23 TKTL1 FBLN2 PTPRS SYNE2 ALDH1B1 OGT BAZ2B ADGRL1 CASQ2 SEMA5A ITIH5 IGF2BP3 HADHA | 1.30e-04 | 819 | 204 | 20 | gudmap_developingGonad_e16.5_testes_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_1000 | PDXDC1 DHX36 TDRD9 MYO7A MYO10 TKTL1 FBLN2 PTPRS ALDH1B1 OGT BAZ2B PUF60 RNF25 ADGRL1 CASQ2 SEMA5A ITIH5 CLIP3 IGF2BP3 HADHA | 1.36e-04 | 822 | 204 | 20 | gudmap_developingGonad_e14.5_ testes_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_DevVascOvary_Flk_top-relative-expression-ranked_1000 | MYH9 NEK6 MYO10 ITGA6 GIT2 PCDH12 PCDH17 NRP1 KCNJ2 HECW2 SCN2A ALDH1B1 PREX1 KLHL4 MID2 RAPGEF4 TJP1 DENND2C ELF4 ARHGEF2 | 1.57e-04 | 831 | 204 | 20 | gudmap_dev gonad_e13.5_F_gudmap_devVascOvary_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_100 | 1.81e-04 | 86 | 204 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_SupCellPrec_Sry_k-means-cluster#3_top-relative-expression-ranked_200 | 2.17e-04 | 57 | 204 | 5 | gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_k3_200 | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 ABCB4 DST BAZ2B RAPGEF4 KLHL5 IGF2BP3 TJP1 LPL | 2.33e-10 | 200 | 211 | 12 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | HECW1 TNFSF10 CHDH BHMT NRP1 TINAG SYNE2 PCDH15 SEMA5A CRYL1 SLC28A1 | 1.16e-09 | 181 | 211 | 11 | 9542c19edc9bd2cba68c01c2a8407705398e3011 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | HECW1 TNFSF10 CHDH BHMT NRP1 TINAG SYNE2 PCDH15 SEMA5A CRYL1 SLC28A1 | 1.16e-09 | 181 | 211 | 11 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 |
| ToppCell | LPS_IL1RA-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST SYNE2 NOVA1 RAPGEF4 SLC12A2 TJP1 | 3.32e-09 | 200 | 211 | 11 | 5c092b2ecc081b5d04476c56333c338cd89ab984 |
| ToppCell | LPS_anti-TNF-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST NOVA1 RAPGEF4 ITIH5 SLC12A2 TJP1 | 3.32e-09 | 200 | 211 | 11 | 1d105eeda5a2c51f9a4654ffc79b7e2348ad593b |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST NOVA1 RAPGEF4 ITIH5 SLC12A2 TJP1 | 3.32e-09 | 200 | 211 | 11 | 60d2cbf41f37f1b11eddb4c9d9246c9c1fc5a5af |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST SYNE2 NOVA1 RAPGEF4 SLC12A2 TJP1 | 3.32e-09 | 200 | 211 | 11 | 72ea9882a8ed26fa1534aeb6ba0d1897dccc20c5 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 184 | 211 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 184 | 211 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-08 | 184 | 211 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 COLEC10 ITIH5 SLC12A2 TJP1 | 2.40e-08 | 188 | 211 | 10 | 73f6ec915934154f435a376cb274b058ff7c5f35 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | NEK6 HECW1 TNFSF10 CHDH NRP1 TINAG SYNE2 SEMA5A GRIP1 SLC28A1 | 2.52e-08 | 189 | 211 | 10 | 28b502611829e4a24caff2562545c7db97686099 |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 NOVA1 KLHL4 RAPGEF4 COLEC10 SLC12A2 | 2.65e-08 | 190 | 211 | 10 | a3c6eec6df052105ab78b7e3c78f94218d5912eb |
| ToppCell | Control-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | MYH9 TNFSF10 MYO10 ITGA6 PCDH17 NRP1 HECW2 PREX1 RAPGEF4 KLHL5 | 2.65e-08 | 190 | 211 | 10 | 7f3f419fffe02934b6f27b697f7a6401072491ed |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 COLEC10 ITIH5 SLC12A2 TJP1 | 2.93e-08 | 192 | 211 | 10 | c618ede75dce3988c87a5b8f98d8e94e1dd66efd |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 COLEC10 ITIH5 SLC12A2 TJP1 | 3.07e-08 | 193 | 211 | 10 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | MYH9 TNFSF10 ITGA6 PCDH17 PCDH15 PREX1 RAPGEF4 KLHL5 PPARGC1B LPL | 3.73e-08 | 197 | 211 | 10 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TNFSF10 PCDH12 PCDH17 DST SYNE2 NOVA1 COLEC10 ITIH5 SLC12A2 TJP1 | 4.30e-08 | 200 | 211 | 10 | 79e51afb57ca38aacebd0298e5e727b55c0cfff9 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST BAZ2B RAPGEF4 IGF2BP3 TJP1 | 4.30e-08 | 200 | 211 | 10 | b2d4e6f3e8e4da62e6b02758ab2ed8f505269f9a |
| ToppCell | LPS_only-Endothelial-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST SYNE2 RAPGEF4 SLC12A2 TJP1 | 4.30e-08 | 200 | 211 | 10 | 4bb609a284d4e6066f17470a1736076aa4a1f84c |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST SYNE2 BAZ2B RAPGEF4 TJP1 | 4.30e-08 | 200 | 211 | 10 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb |
| ToppCell | LPS_only-Endothelial|LPS_only / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST SYNE2 RAPGEF4 SLC12A2 TJP1 | 4.30e-08 | 200 | 211 | 10 | 81e76508c9050d533853d5fd2f3097b27613d836 |
| ToppCell | LPS_anti-TNF-Endothelial-Endothelial-Gen_Cap|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NRP1 DST SYNE2 BAZ2B RAPGEF4 TJP1 | 4.30e-08 | 200 | 211 | 10 | a2b9d1cd291d17abddc3ee2e242121412c864b8b |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 PREX1 RAPGEF4 PPARGC1B SLC12A2 | 1.55e-07 | 174 | 211 | 9 | 4a1b67ce5ea353b3f81f59fa57da07668146afca |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 COLEC10 SLC12A2 TJP1 | 2.06e-07 | 180 | 211 | 9 | 544fb373a3346186ec60afe2cfcf141bb04a1eed |
| ToppCell | 343B-Endothelial_cells-Endothelial-E-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 PREX1 RAPGEF4 PPARGC1B SLC12A2 | 2.73e-07 | 186 | 211 | 9 | dae6a98963c78bf7518ebab8dc02f173c3b0f7f7 |
| ToppCell | 343B-Endothelial_cells-Endothelial-E|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 PREX1 RAPGEF4 PPARGC1B SLC12A2 | 2.73e-07 | 186 | 211 | 9 | 080e56113b89138277a2bd2eabddfa6cd1a18b61 |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 ITIH5 SLC12A2 | 2.98e-07 | 188 | 211 | 9 | 789d1be574e693d7bdd488f3c72c6df788e47b47 |
| ToppCell | COVID-19-kidney-PCT-S2|kidney / Disease (COVID-19 only), tissue and cell type | 3.12e-07 | 189 | 211 | 9 | 0be5c669b6b308bd98ddb70c84877c62a6244bbd | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-07 | 191 | 211 | 9 | 1c1d13144259b998d4a0e85142f7afef2ef1e63f | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.41e-07 | 191 | 211 | 9 | 3c464645d0e7e423f791bd63bf5bcf11f6b590d3 | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 SLC12A2 TJP1 | 3.56e-07 | 192 | 211 | 9 | c07d7b40b2aa4eb27ac85801c014a656e2fd01dc |
| ToppCell | facs-Lung-nan-3m-Endothelial-Capillary_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-07 | 192 | 211 | 9 | 4bab9754cfd8b9c2d7cc1490e8a29f58c3c26f6c | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 SLC12A2 TJP1 | 3.56e-07 | 192 | 211 | 9 | 04f5a2e3dd6beff027b89d66eefdd92036e041af |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 SLC12A2 TJP1 | 3.72e-07 | 193 | 211 | 9 | 02f633b016ab19bfa65bfd0cf32f000549a62148 |
| ToppCell | LPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | TNFSF10 ITGA6 PCDH12 PCDH17 HECW2 NOVA1 RAPGEF4 SLC12A2 TJP1 | 3.72e-07 | 193 | 211 | 9 | 5122b1ffba42de190061be34ecdc6176f84e56a3 |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.89e-07 | 194 | 211 | 9 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-07 | 194 | 211 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.89e-07 | 194 | 211 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.71e-07 | 145 | 211 | 8 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | Control_saline|World / Treatment groups by lineage, cell group, cell type | 4.81e-07 | 199 | 211 | 9 | 11c9c1779caceb725ecccf3f23b7d4e6dbd1af64 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Alv_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | TNFSF10 PCDH12 PCDH17 PREX1 NOVA1 COLEC10 ITIH5 SLC12A2 TJP1 | 5.02e-07 | 200 | 211 | 9 | 7034f57e282982c19c13ee8ab78eabaffa069e30 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 NOVA1 COLEC10 ITIH5 SLC12A2 TJP1 | 5.02e-07 | 200 | 211 | 9 | 58a7ece7dfdf6c46f2a50cbcb580574dec14c748 |
| ToppCell | LPS_IL1RA_TNF-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 ABCB4 NOVA1 RAPGEF4 SLC12A2 TJP1 | 5.02e-07 | 200 | 211 | 9 | d01cec331be3b03cef80e9536fc531285bcf00f6 |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial-Vein|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.02e-07 | 200 | 211 | 9 | 7eb366b2c5394af7c77650bde6261e7dac67154e | |
| ToppCell | Control_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.02e-07 | 200 | 211 | 9 | e77eba6172cabf85b8028638ed35299f2f079cd8 | |
| ToppCell | LPS_IL1RA_TNF-Endothelial-Endothelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | TNFSF10 ITGA6 PCDH12 PCDH17 ABCB4 NOVA1 RAPGEF4 SLC12A2 TJP1 | 5.02e-07 | 200 | 211 | 9 | a1fa6bae5a688faf488d6925cd3fad725dfa916b |
| ToppCell | Control_saline-Endothelial-Endothelial-Activated_Alv_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 5.02e-07 | 200 | 211 | 9 | be55cef682ba87250dad97689332c8820b3a7420 | |
| ToppCell | Control_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type | 5.02e-07 | 200 | 211 | 9 | 3372c488a39fe812fa94e4f0564594186fea3db5 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.09e-06 | 162 | 211 | 8 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 163 | 211 | 8 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.14e-06 | 163 | 211 | 8 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | droplet-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.22e-06 | 114 | 211 | 7 | 84318a25a701331ccd5e68221239c543b9c0cc54 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.37e-06 | 167 | 211 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 167 | 211 | 8 | fcd583b1efd0ac883379982ea8e6c54f2c0be268 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 167 | 211 | 8 | f6bc63138b7239211fa5f27a8dc799b6e022c0f8 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 167 | 211 | 8 | b93103a868fba63a8910bffb690a6242b9252833 | |
| ToppCell | E16.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-06 | 167 | 211 | 8 | 26cd8ee5e826e71eaf58d10a906543a6932fb3f9 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Proximal_Tubule_Epithelial_Cell_Segment_3|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-06 | 179 | 211 | 8 | d1ef7e1cb00336118e387b47f4f8120f53584391 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 180 | 211 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 180 | 211 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Alv_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-06 | 180 | 211 | 8 | 30cf3c7ee29694eaccb89bf8053a82037d5c9f1d | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-06 | 180 | 211 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | COVID-19-kidney-Distal_Epi_Doublet_(PCT)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.60e-06 | 182 | 211 | 8 | 9d67717a6e13bcb54c1297a3e4e3abf4e51628a3 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 183 | 211 | 8 | dc19857b66dcadbf7c87de91f7b1f4e8ef2857ed | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 183 | 211 | 8 | 4759560e5b4f4e5a00e5f933e3451a27c7c4aefe | |
| ToppCell | Control-Epithelial_cells-Airway_mucous|Control / group, cell type (main and fine annotations) | 2.71e-06 | 183 | 211 | 8 | 15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2 | |
| ToppCell | COVID-19-kidney-PCT-S1|kidney / Disease (COVID-19 only), tissue and cell type | 2.82e-06 | 184 | 211 | 8 | 51ed1ebfdef45149541917c66cbacad87072e51f | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)|World / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.06e-06 | 186 | 211 | 8 | 32af3f211f9ad5d5c6b86b83325cfbf2f8466b56 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.18e-06 | 187 | 211 | 8 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 187 | 211 | 8 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 187 | 211 | 8 | dcf6475ece5b34d9d58a0d1f51c18acedb19c119 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.18e-06 | 187 | 211 | 8 | f1356273bd3587b6883295edf15cb9cdb706c057 | |
| ToppCell | COVID-19-kidney|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.18e-06 | 187 | 211 | 8 | d23aae9419d460b78b1d4092d7acd9108a47cfbe | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell-ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-06 | 188 | 211 | 8 | bc0b9ba8ae88e8a89e98b446584ed39606e4229e | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-06 | 188 | 211 | 8 | 50994e304c719f2f3c3232e48141e2dd15c96612 | |
| ToppCell | droplet-Lung-1m-Epithelial-airway_epithelial-lung_ciliated_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.31e-06 | 188 | 211 | 8 | a7b7ba56603a8a50869b41902aed6a9ab1c5c021 | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 211 | 8 | b98f60875b1a12b2ec9dc91889298ae57f98602f | |
| ToppCell | facs-Heart-RA-24m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-06 | 189 | 211 | 8 | e758b264c0a47127e33e66c395cf5a3224c7305b | |
| ToppCell | LPS_only-Endothelial-Endothelial-Alv_Cap|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-06 | 190 | 211 | 8 | 474cbbab8f3b0a6881fa6c92edb78e43999f9ab0 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Alv_Gen_Intermediate|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.58e-06 | 190 | 211 | 8 | 106ea0bb7b99c697ffc5443d72343df2484250c7 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 191 | 211 | 8 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.72e-06 | 191 | 211 | 8 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)|World / Lineage, Cell type, age group and donor | 3.87e-06 | 192 | 211 | 8 | 1e156bab5ecf64627890d2de9b27603d9a01f28d | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 192 | 211 | 8 | 0bf99e029a06151092db1e8a0dcb45f4e688e771 | |
| ToppCell | droplet-Heart-nan-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 192 | 211 | 8 | d766221acfce30cbf2c60b3ae40f6744968b952c | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-06 | 193 | 211 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | Control-Endothelial-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-06 | 193 | 211 | 8 | aff0649c73c634bc6ff0dc7759b4693a9236bf05 | |
| ToppCell | Control-Endothelial|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.02e-06 | 193 | 211 | 8 | c5f9fe03e64c211d4bcd4959e5b32f14841e336a | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.18e-06 | 194 | 211 | 8 | f159ef8541d75a4e98468947f231bb463bec922c | |
| ToppCell | IPF-Endothelial-VE_Capillary_A|Endothelial / Disease state, Lineage and Cell class | 4.18e-06 | 194 | 211 | 8 | 777ce41c3f22c591e2d81120f189b834e53ffb4b | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.18e-06 | 194 | 211 | 8 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 196 | 211 | 8 | a582130862bee76c0385156a333bfdfc75cf218b | |
| ToppCell | droplet-Heart-HEART-1m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.51e-06 | 196 | 211 | 8 | fba52a4b82086dbae9a55038bf44c4539be926f5 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 196 | 211 | 8 | 49cc0a2b9739abad61dff7292ea0b14d28ff35c4 | |
| ToppCell | Fetal_29-31_weeks-Endothelial|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.51e-06 | 196 | 211 | 8 | 3981f6c7487598f4f7ce4650ac0ac5bd41481d66 | |
| ToppCell | COVID-19-lung-Capillary_Aerocytes|lung / Disease (COVID-19 only), tissue and cell type | 4.51e-06 | 196 | 211 | 8 | 4ac4073380d939a73cec7413e9f3f5ef616d2924 | |
| ToppCell | ASK452-Endothelial-Endothelium|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 4.85e-06 | 198 | 211 | 8 | e282769f5fa1765bcce79a0ed9d761bf2e14b012 | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.3|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.85e-06 | 198 | 211 | 8 | d5990cab01de6e6f3757f5a50ef70ced711bb1fa | |
| ToppCell | normal_Lung-Endothelial_cells-Tip-like_ECs|Endothelial_cells / Location, Cell class and cell subclass | 5.04e-06 | 199 | 211 | 8 | 72c96a5954dfcfbfee8f095984ce1f5249d9a679 | |
| Drug | clenbuterol | 8.29e-07 | 142 | 210 | 10 | CID000002783 | |
| Drug | purealin | 1.04e-06 | 58 | 210 | 7 | CID006419303 | |
| Drug | blebbistatin | 1.32e-06 | 116 | 210 | 9 | CID003476986 | |
| Drug | formycin triphosphate | 7.30e-06 | 51 | 210 | 6 | CID000122274 | |
| Drug | verapamil | MYH6 MYH9 ABCA4 MYO5A CACNA2D2 CHRNB1 RYR2 ABCB4 KCNJ2 SCN3A SCN10A VPS51 ABCC1 HTR7 MYH14 LTA4H | 1.38e-05 | 490 | 210 | 16 | CID000002520 |
| Drug | APETx1, Anthopleura elegantissima | 1.52e-05 | 6 | 210 | 3 | ctd:C475726 | |
| Drug | fenpropathrin | 1.52e-05 | 6 | 210 | 3 | ctd:C044267 | |
| Drug | Triflusal [322-79-2]; Down 200; 16.2uM; HL60; HG-U133A | 1.55e-05 | 197 | 210 | 10 | 1717_DN | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 1.69e-05 | 199 | 210 | 10 | 6219_DN | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 2.18e-05 | 37 | 210 | 5 | CID000009643 | |
| Disease | Nonsyndromic genetic hearing loss | 1.10e-06 | 76 | 207 | 7 | cv:C5680182 | |
| Disease | Nonsyndromic Deafness | 1.69e-06 | 81 | 207 | 7 | C3711374 | |
| Disease | Usher syndrome, type 1A | 3.37e-06 | 5 | 207 | 3 | C2931205 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 3.37e-06 | 5 | 207 | 3 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 3.37e-06 | 5 | 207 | 3 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 3.37e-06 | 5 | 207 | 3 | C1848640 | |
| Disease | Usher syndrome type 1 | 3.37e-06 | 5 | 207 | 3 | cv:C1568247 | |
| Disease | hearing impairment | 6.09e-06 | 98 | 207 | 7 | C1384666 | |
| Disease | Usher Syndrome, Type I | 6.70e-06 | 6 | 207 | 3 | C1568247 | |
| Disease | Hereditary retinal dystrophy | 1.17e-05 | 7 | 207 | 3 | C0154860 | |
| Disease | Usher syndrome | 1.17e-05 | 7 | 207 | 3 | cv:C0271097 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 2.93e-05 | 51 | 207 | 5 | cv:CN043650 | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 3.94e-05 | 10 | 207 | 3 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 3.94e-05 | 10 | 207 | 3 | DOID:0080422 (implicated_via_orthology) | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1 (disorder) | 3.94e-05 | 10 | 207 | 3 | C1631597 | |
| Disease | Usher syndrome, type 1D | 4.90e-05 | 2 | 207 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 4.90e-05 | 2 | 207 | 2 | C1832845 | |
| Disease | USHER SYNDROME, TYPE ID | 4.90e-05 | 2 | 207 | 2 | 601067 | |
| Disease | Usher syndrome type 1D | 4.90e-05 | 2 | 207 | 2 | cv:C1832845 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 4.90e-05 | 2 | 207 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | Tachycardia, Ventricular | 5.39e-05 | 11 | 207 | 3 | C0042514 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 7.14e-05 | 12 | 207 | 3 | DOID:0060170 (implicated_via_orthology) | |
| Disease | Hereditary hearing loss and deafness | 8.04e-05 | 146 | 207 | 7 | cv:C0236038 | |
| Disease | sensorineural hearing loss (is_implicated_in) | 8.21e-05 | 33 | 207 | 4 | DOID:10003 (is_implicated_in) | |
| Disease | non-alcoholic fatty liver disease (biomarker_via_orthology) | 9.50e-05 | 65 | 207 | 5 | DOID:0080208 (biomarker_via_orthology) | |
| Disease | Catecholaminergic polymorphic ventricular tachycardia 1 | 1.46e-04 | 3 | 207 | 2 | cv:C1631597 | |
| Disease | VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY | 1.46e-04 | 3 | 207 | 2 | 604772 | |
| Disease | congenital nystagmus (is_implicated_in) | 1.46e-04 | 3 | 207 | 2 | DOID:9649 (is_implicated_in) | |
| Disease | Stress-induced polymorphic ventricular tachycardia | 2.91e-04 | 4 | 207 | 2 | C2677794 | |
| Disease | Usher Syndrome | 2.91e-04 | 4 | 207 | 2 | C0271097 | |
| Disease | anxiety disorder (implicated_via_orthology) | 4.75e-04 | 22 | 207 | 3 | DOID:2030 (implicated_via_orthology) | |
| Disease | progranulin measurement | 4.75e-04 | 22 | 207 | 3 | EFO_0004625 | |
| Disease | Familial ventricular tachycardia | 4.83e-04 | 5 | 207 | 2 | C0340485 | |
| Disease | Usher Syndrome, Type II | 4.83e-04 | 5 | 207 | 2 | C1568249 | |
| Disease | Leber congenital amaurosis (is_implicated_in) | 7.21e-04 | 6 | 207 | 2 | DOID:14791 (is_implicated_in) | |
| Disease | Disorder of eye | 7.78e-04 | 212 | 207 | 7 | C0015397 | |
| Disease | methionine measurement | 7.85e-04 | 26 | 207 | 3 | EFO_0009771 | |
| Disease | polycystic ovary syndrome | 8.44e-04 | 60 | 207 | 4 | EFO_0000660 | |
| Disease | Atrial Fibrillation | 9.60e-04 | 160 | 207 | 6 | C0004238 | |
| Disease | orofacial cleft (is_implicated_in) | 1.00e-03 | 7 | 207 | 2 | DOID:0050567 (is_implicated_in) | |
| Disease | fish oil supplement exposure measurement, high density lipoprotein cholesterol measurement | 1.00e-03 | 7 | 207 | 2 | EFO_0004612, EFO_0600007 | |
| Disease | Usher Syndrome, Type III | 1.00e-03 | 7 | 207 | 2 | C1568248 | |
| Disease | triglycerides to total lipids in medium VLDL percentage | 1.01e-03 | 63 | 207 | 4 | EFO_0022335 | |
| Disease | cholesterol to total lipids in medium VLDL percentage | 1.01e-03 | 63 | 207 | 4 | EFO_0022239 | |
| Disease | Epilepsy | 1.05e-03 | 109 | 207 | 5 | C0014544 | |
| Disease | epilepsy (implicated_via_orthology) | 1.06e-03 | 163 | 207 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Autosomal dominant nonsyndromic hearing loss | 1.09e-03 | 29 | 207 | 3 | cv:C5779548 | |
| Disease | Ciliopathies | 1.09e-03 | 110 | 207 | 5 | C4277690 | |
| Disease | Myopathy | 1.20e-03 | 30 | 207 | 3 | C0026848 | |
| Disease | irritable bowel syndrome (biomarker_via_orthology) | 1.33e-03 | 8 | 207 | 2 | DOID:9778 (biomarker_via_orthology) | |
| Disease | health-related quality of life measurement | 1.71e-03 | 9 | 207 | 2 | EFO_0011014 | |
| Disease | amnestic disorder (implicated_via_orthology) | 1.71e-03 | 9 | 207 | 2 | DOID:10914 (implicated_via_orthology) | |
| Disease | cholestasis (implicated_via_orthology) | 1.71e-03 | 9 | 207 | 2 | DOID:13580 (implicated_via_orthology) | |
| Disease | fish oil supplement exposure measurement, triglyceride measurement | 2.12e-03 | 10 | 207 | 2 | EFO_0004530, EFO_0600007 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.12e-03 | 10 | 207 | 2 | OBA_2045163 | |
| Disease | Cardiomyopathies | 2.28e-03 | 130 | 207 | 5 | C0878544 | |
| Disease | tumor necrosis factor receptor superfamily member 11B measurement | 2.58e-03 | 11 | 207 | 2 | EFO_0020801 | |
| Disease | Shortened QT interval | 2.58e-03 | 11 | 207 | 2 | C0151879 | |
| Disease | level of Ceramide (d40:1) in blood serum | 2.58e-03 | 11 | 207 | 2 | OBA_2045185 | |
| Disease | Autism Spectrum Disorders | 3.06e-03 | 85 | 207 | 4 | C1510586 | |
| Disease | level of Diacylglycerol (18:1_18:2) in blood serum | 3.09e-03 | 12 | 207 | 2 | OBA_2045171 | |
| Disease | triacylglycerol 56:6 measurement | 3.42e-03 | 43 | 207 | 3 | EFO_0010433 | |
| Disease | triglycerides in large LDL measurement | 3.42e-03 | 43 | 207 | 3 | EFO_0022319 | |
| Disease | free cholesterol to total lipids in very small VLDL percentage | 3.42e-03 | 43 | 207 | 3 | EFO_0022290 | |
| Disease | tumor necrosis factor ligand superfamily member 11 measurement | 3.63e-03 | 13 | 207 | 2 | EFO_0010617 | |
| Disease | forced expiratory volume | DIS3L2 TDRD9 PLEKHM1 RYR2 DST OSBPL6 PCDH15 KIAA2012 PREX1 IGF2BP3 ARHGAP12 SKAP1 NNT | 3.97e-03 | 789 | 207 | 13 | EFO_0004314 |
| Disease | triacylglycerol 54:4 measurement | 4.14e-03 | 46 | 207 | 3 | EFO_0010422 | |
| Disease | osteoprotegerin measurement | 4.22e-03 | 14 | 207 | 2 | EFO_0005918 | |
| Disease | Colonic Neoplasms | 4.46e-03 | 152 | 207 | 5 | C0009375 | |
| Disease | Intellectual Disability | 4.51e-03 | 447 | 207 | 9 | C3714756 | |
| Disease | triacylglycerol 52:3 measurement | 4.84e-03 | 15 | 207 | 2 | EFO_0010415 | |
| Disease | P wave duration | 4.84e-03 | 15 | 207 | 2 | EFO_0005094 | |
| Disease | infant head circumference | 4.84e-03 | 15 | 207 | 2 | EFO_0004577 | |
| Disease | level of Triacylglycerol (53:3) in blood serum | 4.84e-03 | 15 | 207 | 2 | OBA_2045165 | |
| Disease | high density lipoprotein cholesterol measurement, metabolic syndrome | 4.84e-03 | 15 | 207 | 2 | EFO_0000195, EFO_0004612 | |
| Disease | Sinus Node Dysfunction (disorder) | 4.84e-03 | 15 | 207 | 2 | C0428908 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 4.93e-03 | 222 | 207 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | cholestasis (biomarker_via_orthology) | 4.94e-03 | 49 | 207 | 3 | DOID:13580 (biomarker_via_orthology) | |
| Disease | Paroxysmal atrial fibrillation | 4.97e-03 | 156 | 207 | 5 | C0235480 | |
| Disease | familial atrial fibrillation | 4.97e-03 | 156 | 207 | 5 | C3468561 | |
| Disease | Persistent atrial fibrillation | 4.97e-03 | 156 | 207 | 5 | C2585653 | |
| Disease | triglycerides to total lipids in medium LDL percentage | 5.23e-03 | 50 | 207 | 3 | EFO_0022334 | |
| Disease | polyunsaturated fatty acids to total fatty acids percentage | 5.23e-03 | 50 | 207 | 3 | EFO_0022303 | |
| Disease | Malignant tumor of colon | 5.38e-03 | 159 | 207 | 5 | C0007102 | |
| Disease | Myasthenic Syndromes, Congenital, Slow Channel | 5.51e-03 | 16 | 207 | 2 | C0751885 | |
| Disease | triiodothyronine measurement | 5.51e-03 | 16 | 207 | 2 | EFO_0008392 | |
| Disease | peanut allergy measurement | 5.51e-03 | 16 | 207 | 2 | EFO_0007017 | |
| Disease | triglycerides to total lipids in large LDL percentage | 5.53e-03 | 51 | 207 | 3 | EFO_0022331 | |
| Disease | phospholipids in very small VLDL measurement | 5.53e-03 | 51 | 207 | 3 | EFO_0022300 | |
| Disease | polyunsaturated fatty acids to monounsaturated fatty acids ratio | 5.53e-03 | 51 | 207 | 3 | EFO_0022302 | |
| Disease | mean platelet volume | MYH9 MYO5A ITGA6 PSMD13 RCOR1 SYNE2 KIF28P ZAN PCDHGB3 AAMDC SIK3 LPL DENND2C IRS2 NNT | 5.78e-03 | 1020 | 207 | 15 | EFO_0004584 |
| Disease | generalised epilepsy | 5.84e-03 | 52 | 207 | 3 | EFO_0005917 | |
| Disease | monoclonal gammopathy | 6.16e-03 | 53 | 207 | 3 | EFO_0000203 | |
| Disease | free cholesterol to total lipids in small LDL percentage | 6.16e-03 | 53 | 207 | 3 | EFO_0022286 | |
| Disease | cholesteryl esters to total lipids in very large VLDL percentage | 6.16e-03 | 53 | 207 | 3 | EFO_0022258 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 6.21e-03 | 17 | 207 | 2 | C0751883 | |
| Disease | Lipidemias | 6.21e-03 | 17 | 207 | 2 | C1706412 | |
| Disease | food allergy measurement | 6.21e-03 | 17 | 207 | 2 | EFO_0007016 | |
| Disease | Hyperlipidemia | 6.21e-03 | 17 | 207 | 2 | C0020473 | |
| Disease | Peripheral Nervous System Diseases | 6.49e-03 | 54 | 207 | 3 | C4721453 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VKEYNALVAQGVRVG | 101 | Q9H7C9 | |
| RGNYVLEKISGQEVN | 86 | Q93088 | |
| EILNGGVYVDQNKFL | 141 | Q15303 | |
| VNKFNVLYDRQGIGR | 306 | Q7L5N1 | |
| RIFGGVQQLREIYKD | 86 | Q9NY47 | |
| TEYLVRFEEQGLGLQ | 806 | P78363 | |
| NGVVKVVFILYNNLG | 721 | O94910 | |
| RNFGKVLGFDVNIDV | 1101 | Q9UIF8 | |
| QFERVLGYIQLGQKE | 366 | P30837 | |
| EGIYQLEKGARLQEI | 431 | Q92974 | |
| VEAQCKVELRGNGIY | 786 | Q9UK96 | |
| FVRIFEGEGYINLNQ | 66 | A7E2U8 | |
| GGREGQRQEVIFYLI | 226 | P11230 | |
| RVFIGVNDLEREGQY | 206 | Q9Y6Z7 | |
| KAGQILQAELLAVYG | 176 | Q14161 | |
| NLAIGFDIYKVEENR | 421 | O15484 | |
| NGQTAAVEFLLYRGK | 901 | Q8NB46 | |
| GILKQAFDVLVLRYG | 776 | Q8IYB7 | |
| ITVQGLVDREKGDFY | 1371 | Q9H251 | |
| GQIFLETELFYKGIR | 391 | P25705 | |
| LFEGTRAVGVEYVKN | 266 | Q8NE62 | |
| ILQFIQGAEYEGKDL | 216 | Q8N9B4 | |
| YGRDFQAISDVIGNK | 401 | Q9UKL0 | |
| IDGRKANVNLAYLGA | 76 | Q9BX46 | |
| LGELLQQFGELKYVR | 351 | Q9NW13 | |
| LADQGEIRVGCKYQA | 141 | O94776 | |
| GLIRVKGNLDYEENG | 301 | O14917 | |
| GKEYVRQLVYVEQAG | 391 | Q9C0H5 | |
| LVGYSQKIELFGAVQ | 196 | Q9NV88 | |
| YRGVIANVALFDGVV | 266 | Q8N442 | |
| DADLGINGKVSYRIQ | 486 | Q9NPG4 | |
| VQFINVGEKGQRYLA | 56 | P63252 | |
| VINGQEVKYALGERQ | 66 | P09960 | |
| QDAQDLYAAGEKIRG | 181 | P13928 | |
| LQRNKLYVTFVGEEG | 1241 | Q9P2P5 | |
| AIENIIGRDYKGVLQ | 271 | Q5VYV0 | |
| KYFGDIISVGQRLLQ | 131 | Q96CN7 | |
| YRLVINDGKLGAQSV | 131 | Q9BX68 | |
| FGAVLQGEYLGQKVA | 246 | P42679 | |
| IERAGYSLEKVFGIQ | 321 | Q9UNF1 | |
| FSGLGNIIKNEALYR | 226 | Q969S2 | |
| QNGILGDFIIRYDVN | 251 | Q86UX2 | |
| REQSIGDIQVLNGYF | 266 | Q86UX2 | |
| QKGDVVDVYQREFLA | 31 | Q9UQ53 | |
| ENIFGNYIVQKGLAV | 2106 | Q9UKN7 | |
| GILAKVEGQRLVYQF | 276 | Q99607 | |
| AQEQGDKVGEARALY | 136 | Q86YR5 | |
| DKVGEARALYNIGNV | 141 | Q86YR5 | |
| QVEQIGDNKYRFFLG | 7296 | Q03001 | |
| QRNKLYVTFVGEEGL | 1276 | Q76N89 | |
| LEVVKQFRDGGYNTL | 526 | Q8IYD8 | |
| FIQIYGQKGRTDEIL | 446 | Q8IVV2 | |
| DIYTGLFNVGNKLLV | 801 | Q12766 | |
| QGLKAGAIYVFQVRA | 496 | P29323 | |
| TIALNIIKGNEEGYF | 1116 | P98095 | |
| IRINFDVAGYIVGAN | 266 | Q7Z406 | |
| GIRAEQVNKKGIEFY | 121 | Q6UWM7 | |
| GYTKLVGQDVARFIN | 126 | P06858 | |
| QYLGLDGFVERIKHA | 346 | Q6P996 | |
| SGEVQLLQGERYKLV | 426 | Q92817 | |
| EAYKRGIIDRGQYLQ | 1701 | Q92817 | |
| RYNSGKLEEFVQGNL | 46 | P00740 | |
| RDIRKGEFVNEYVGE | 1081 | O96028 | |
| LAEIYGIEGNIFRLK | 71 | Q8TET4 | |
| NGNDFIVIELVKGYI | 961 | Q9P2S2 | |
| GEVQYDVRGILEKNR | 551 | Q9HD67 | |
| QIEKKIGRGQFSEVY | 46 | Q9HC98 | |
| DLKEAILAYGRQQGE | 111 | Q0VF49 | |
| INLYKQLVRGEEVNG | 291 | Q9UJY5 | |
| VRDILYVFQGIDGKN | 251 | Q96CW5 | |
| GKFIRINFDVNGYIV | 236 | P35579 | |
| VGRLGYLQALVTEFQ | 11 | Q9H6L4 | |
| GSLIEYEFRVINLGK | 866 | P23229 | |
| AQGDGLIKLYENFIS | 51 | Q9UNM6 | |
| EIIYAFINIGKEVRQ | 276 | Q9Y5G1 | |
| QLESGGFEARLYVKQ | 16 | Q8IYI6 | |
| IEKYGQGRLQTAVAE | 381 | Q96RP7 | |
| QFGVAVLDDKLYVVG | 506 | Q96PQ7 | |
| DIYKVFNGEGEQIRA | 456 | Q9UKS7 | |
| VVIDQEGKAVYRLFG | 781 | Q9BZF3 | |
| VAVIDNKLYVVGGRD | 471 | Q9C0H6 | |
| AQGRIYGKIKEENFV | 466 | O00425 | |
| RNGYQGLVDELAKDI | 1456 | Q86VI3 | |
| NIEGKRNDQDYVLGR | 666 | Q96JM4 | |
| NGLDVLFKVVRYEGF | 261 | Q02978 | |
| QAVREKGYIKDQVFG | 641 | Q8IWW6 | |
| VIAFGGQNKELERYQ | 266 | P21439 | |
| YKIQYNGLTLDVDGR | 1066 | Q13332 | |
| NTRVYEKVLLGVVGF | 206 | Q8NGQ1 | |
| LYQVIFEGEIGKGNL | 776 | O14786 | |
| IYQQAEKARLQGGVL | 246 | P11117 | |
| GFQNGLNYIAIDVRE | 1246 | Q9Y4H2 | |
| YEILVGAQGDFIINK | 546 | Q96QU1 | |
| LVALQYGFANGEVKA | 431 | O95838 | |
| QDAQDLYAAGEKIRG | 181 | Q5VT79 | |
| RLLQGLGYTVVDEKN | 221 | P51878 | |
| QLRQNLYLVGFGKAV | 76 | Q8IVS8 | |
| ENGFIRNEKQLYLVG | 651 | P13671 | |
| RGIEITVNYLGIQFD | 321 | B7ZAQ6 | |
| RGIEITVNYLGIQFD | 321 | P0CG08 | |
| YQVVLGEYNLAVKEG | 81 | P09093 | |
| TQFILDNYIERGKGS | 241 | Q9H2U1 | |
| KLNVGNERYVFEAVI | 186 | Q9H2C0 | |
| YEIRINGDNGYSKIL | 591 | Q5T1B0 | |
| YLQSLFQEVGIKVDG | 156 | O75417 | |
| FALRVLGQVNKYVEQ | 1081 | P01031 | |
| FVDQYGQRDDGKIGI | 61 | P05937 | |
| IQDRVGLLYQFVGAT | 416 | Q9H222 | |
| QVLQEAYRVLKHGGE | 166 | Q9HBK9 | |
| LGRGKYSEVFEAINI | 46 | P19784 | |
| SGVKGLFEIRAIQYL | 886 | Q68D51 | |
| KGGYFSVNLNEEILR | 161 | Q6P1S2 | |
| FLRKEYGGLDVLVNN | 76 | P16152 | |
| FLRKEYGGLNVLVNN | 76 | O75828 | |
| INYGVKGDVAVVRIN | 41 | P40939 | |
| LLTFIYNGRVVGEAQ | 221 | Q00978 | |
| GYEFLEILKQVARDN | 281 | O14958 | |
| ELAYQIAEQFRVLGK | 81 | Q9Y6V7 | |
| VQKEVAGFVLNRLQY | 186 | Q9Y2S2 | |
| VNYGENIDDQRKGLI | 491 | Q8IW92 | |
| KDLGRALGILVYVFN | 1881 | Q9NYC9 | |
| QKGYLQIIEQALEAG | 3491 | Q9NYC9 | |
| QVLVAGQKQGIVRFY | 421 | Q96DZ5 | |
| YVGDRAIDNIKGLQG | 1081 | P82279 | |
| DVGDYIKAVNGINLA | 96 | Q9Y3R0 | |
| DYRGLEQLKAQLVAG | 461 | Q86YV9 | |
| GIRYVVDGGFVKQLN | 356 | Q8IX18 | |
| KRNGGFVELLFIIYD | 216 | Q9Y2B1 | |
| LQINGYAVSRGFKDL | 2896 | Q92736 | |
| GRIVVFQYSDGKLQT | 846 | Q16531 | |
| REDQQLGFYVEGLKS | 181 | B7ZC32 | |
| GNVYKERGQLQEAIE | 96 | O15294 | |
| QLAGEQGYIRLIFQG | 401 | Q96FA3 | |
| RTNTGEDGQYFLKVL | 41 | P51513 | |
| RVIVLDKGEIQEYGA | 1496 | P33527 | |
| ARGVKNLNFYDVVLD | 456 | Q8NAN2 | |
| YRVAGAQIQGAKEVL | 106 | Q13423 | |
| RDGVGDGQLKTLVNY | 701 | Q96J94 | |
| DLVVKYLQGVYQEVG | 626 | Q2TAK8 | |
| YQEVGAKVLQRTNGD | 636 | Q2TAK8 | |
| QQIADGVYEGFLKAL | 966 | Q9Y4G2 | |
| QLAQYNFILVVGEKE | 666 | P26639 | |
| YENLEKGITLFRQGD | 61 | Q8WZA2 | |
| YLKVDAQFGGIDQRK | 176 | P54577 | |
| FTLFGVYGDVQRVKI | 356 | Q9UKA9 | |
| GAVNRVIIYQEKQGE | 491 | Q9UHX1 | |
| GLQRALQGDYKDVVN | 116 | Q6UWJ1 | |
| ERISFYQQIKRNIGG | 4876 | Q8WXH0 | |
| IELRIDQNGKYYTGV | 1236 | Q8NDG6 | |
| RVNFDDYTVNLGGLK | 361 | Q06210 | |
| LKLQAGAVGRVVDYQ | 151 | Q969Y0 | |
| AIQGNAFARVKIGDY | 546 | Q5TEA6 | |
| ALNVIVDLLEKYGQG | 126 | Q0VDG4 | |
| VAIREAYEAGLIGKN | 171 | P49821 | |
| ELLDKAQVGQAYVGR | 236 | Q9Y6C5 | |
| DYREQAQQIELKTGG | 631 | Q5JRX3 | |
| GLQVGRKIYSINEDL | 661 | Q8TCU6 | |
| KAIGEGRVVYIQNLS | 896 | Q86YN6 | |
| YEIDRTIGKGNFAVV | 66 | Q9Y2K2 | |
| GGVFIQGKRYNVADV | 186 | Q9H1N7 | |
| QFLAVGSYDGKVRIL | 236 | Q9P2S5 | |
| VKVNFDNVGAGYLAL | 1396 | Q9NY46 | |
| GNIDAAKDIIRYIIG | 271 | P20701 | |
| KQPRQYFIGVLDIAG | 451 | P13533 | |
| GQRTFGENYVQELLE | 61 | O94903 | |
| NEVTGTLRIKGYFDQ | 141 | Q13405 | |
| QKGLYRIGFIEEVKA | 226 | Q96P63 | |
| ANFLGNVKRLYEAEV | 146 | Q86WD7 | |
| GGLLVAVVVKYADNI | 281 | P78381 | |
| KEECQNYIRVLLVGG | 111 | Q13591 | |
| DIVDIRNALVGGYKN | 291 | Q8N9L9 | |
| GEQINYGRVEKVVIG | 71 | P34969 | |
| GYVNIIKILLNAGAE | 1166 | Q8IWZ3 | |
| DVGKRLQVGQELIDY | 16 | Q7Z460 | |
| LVQLAVDKGYRIAEG | 276 | Q9NUD9 | |
| KQYGLGAQEEDAFVR | 76 | Q96HA9 | |
| QVGLLYEEGVRKAQS | 626 | Q9UID3 | |
| IALEGANVIYKRDVG | 31 | P62380 | |
| GDRGQVTIQLAQKVY | 256 | Q8TC36 | |
| NEEYGLRLGSQIFVK | 316 | Q9UDY2 | |
| AVRINGDGQEVLYLA | 21 | P0DPA2 | |
| LRLFVNGEVVSAQGY | 311 | Q9NXB0 | |
| KDFNVGGYIQAVLDR | 256 | P11217 | |
| INVAAEKGANGVIIY | 116 | Q8N7C7 | |
| FALVGKQLLGENYRN | 801 | Q9Y5Y9 | |
| EGVNVERYKQIVLTG | 231 | Q96QK1 | |
| IYLDELQVIKGNGRT | 26 | Q96BH1 | |
| FDIQYGVVVIRLKEG | 911 | P55011 | |
| VKVNFDNVGLGYLSL | 1401 | Q99250 | |
| YGVEIKVQNISLREG | 281 | Q53EL9 | |
| ENGVLQIRYAKLGDT | 506 | Q9Y6N7 | |
| EAARLGLGQQEAKLY | 1726 | O43151 | |
| AGFGRKDVVEYLLQN | 66 | Q9H2K2 | |
| REEGVKLTYGDAQNL | 396 | O00337 | |
| LGLGRIVQAEEYLFQ | 141 | Q9H0C1 | |
| RDAEGNYKGVLLTQE | 146 | Q96SE7 | |
| EVFRVVDTLYNGKLG | 541 | Q07157 | |
| YRDGIDAGKAVTLQQ | 46 | Q9NRH1 | |
| GRDIEGVIKQYNKFV | 246 | Q9NWZ5 | |
| SFDIGIQIGYQRRNK | 111 | Q14CZ0 | |
| IAYGRKLGGSQEDQI | 66 | P37837 | |
| NEVQGFLFGKLKEIY | 266 | Q9NYU1 | |
| VRSELIEQVNKGDYG | 156 | Q9UJW2 | |
| GTRYIFIVKAINQAG | 506 | Q9UJV3 | |
| SIYQGGIFELKENDR | 241 | P50591 | |
| LIVKNYTGDRLNFGL | 106 | Q3LXA3 | |
| QFLVIKNGLELYAGL | 81 | A6NGA9 | |
| LDKIDQQYLNEIVGG | 131 | Q99633 | |
| GAQELDNVIKQGYLE | 101 | Q86WV1 | |
| KLGYANNRVVVLDGD | 301 | P51854 | |
| IFQRLIYADKQEVQG | 701 | Q15386 | |
| TNENRGGILEVSYIK | 1586 | Q9Y493 | |
| YGYKVQLQAGLELVV | 2396 | Q9Y493 | |
| VGYGDRSRFIQLVQK | 691 | Q5T447 | |
| LGLKQALEFAYTGQI | 91 | Q96NJ5 | |
| AVQRKLYVLGGNDLD | 491 | Q96NJ5 | |
| QIRLEKNVGGRYELA | 136 | Q86YQ2 | |
| GEIAQAYIGLKETNR | 1306 | Q9Y4I1 | |
| FNKRGAIEGAKIEQY | 221 | Q13402 | |
| LIYQQVVRGVKFGEY | 1366 | Q13402 | |
| EKEQLQGLNDRFAGY | 101 | P07197 |